BriaCell Therapeutics BCTX
NASDAQ BCTX
$3.61 +0.15 (+4.34%)
As of: Oct 21, 2026 · 1:06 PM EDT

BriaCell Therapeutics (BCTX) Share-based Compensation (IS) (2021 - 2022)

Updated

BriaCell Therapeutics (BCTX) recorded Share-based Compensation (IS) of $1.59 million in fiscal Q3 2022 (quarter ended Apr 30, 2022), down 21.0% from $2.01 million a year earlier but up 44.1% from the prior quarter.

Analysis

BriaCell Therapeutics (BCTX) Share-based Compensation (IS) (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn -
2 Johnson & Johnson 616.05 Bn 534.58 Bn 17.26 Bn -
3 AbbVie 500.90 Bn 474.01 Bn 12.70 Bn -
4 Merck 367.17 Bn 321.54 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn -
7 Amgen 235.77 Bn 191.17 Bn 7.24 Bn -
8 Gilead Sciences 190.70 Bn 164.90 Bn 6.22 Bn -
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn -
10 BriaCell Therapeutics 26.17 Mn -54.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2022 1.59 Mn
Jan 31, 2022 1.10 Mn
Apr 30, 2021 2.01 Mn
API Access

BriaCell Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=BCTX&period=max&api_key=YOUR_API_KEY